MECHANISMS OF SUSCEPTIBILITY TO ALLOXAN IN MICE
MECHANISMS OF SUSCEPTIBILITY TO ALLOXAN IN MICE
批准号:
6350638
负责人:
CLAYTON E MATHEWS
金额:
$1.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
未结题
起止时间:
2001-01-02 至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Free radicals are reactive oxygen species that are especially
damaging to pancreatic Beta-cell They are generated within Beta-cell
They are generated within Beta-cells by the combination of cytokines
secreted by leukocytes comprising the insulitic infiltrate during
development of insulin dependent diabetes (IDDM). Destructive oxygen
free radicals are generated in Beta-cells after exposure to
environmental toxins, such as alloxan (AL). Al, resembling the
glucose molecule, is selectively taken up rodent Beta-cell wherein it
decomposes to produce highly toxic oxygen free radicals. Beta-cells
have weaker defenses to oxidative damage than do cells from other
tissues. Unknown whether or not genes expressed in B-cells can
contribute to the overall make-up of an individual is genetically
susceptible or resistant to Beta-cell loss. The goal of this
fellowship proposal is to address this question using two inbred
strains of mice selected for alloxan susceptibility (ALS) versus
(ALR) IDDM induction. The basis for this differential in alloxan
susceptibility is apparently the ability of the ALR strain to
~defuse~ the alloxan-generated free radical stress. The same pattern
of susceptibility/resistance holds for treatment with streptozotocin,
another Beta cell toxin. Biochemical analyze will test whether the
strains different in systemic and/or islet defenses to the reactive
oxygen species generate AL. Genetic segregation analysis will
elucidate the gene or genes controlling differential susceptibility.
Finally, Islets in vitro will be tested for ability to resist free
radical mediated stress induced by combinations of cytotoxic
cytokines. The elucidation of the genetic basis for the heightened
resistance to Beta cell toxins should have practical applications in
therapies for IDDM, including islet transplantation.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Chapter 24 Quantification, localization, and tissue specificities of mouse mitochondrial reactive oxygen species production.
第24章小鼠线粒体活性氧产生的定量、定位和组织特异性。
DOI:
10.1016/s0076-6879(08)04424-8
发表时间:
2009
期刊:
Methods in enzymology
影响因子:
--
作者:
[Gusdon,AaronM, Chen,Jing, Votyakova,TatyanaV, Mathews,ClaytonE]
通讯作者:
Mathews,ClaytonE
Reevaluation of the major histocompatibility complex genes of the NOD-progenitor CTS/Shi strain.
重新评估 NOD 祖细胞 CTS/Shi 菌株的主要组织相容性复合体基因。
DOI:
10.2337/diabetes.49.1.131
发表时间:
2000
期刊:
Diabetes
影响因子:
7.7
作者:
[Mathews,CE, Graser,RT, Serreze,DV, Leiter,EH]
通讯作者:
Leiter,EH
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
-
批准号:10589578
-
项目类别:
-
资助金额:$71.57万
-
财政年份:2023
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
-
批准号:10903049
-
项目类别:
-
资助金额:$119.25万
-
财政年份:2023
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
-
批准号:10417267
-
项目类别:
-
资助金额:$116.62万
-
财政年份:2020
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Organ Specific Project
-
批准号:10685591
-
项目类别:
-
资助金额:$158.75万
-
财政年份:2020
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Organ Specific Project
-
批准号:10259784
-
项目类别:
-
资助金额:$70.21万
-
财政年份:2020
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Organ Specific Project
-
批准号:10118877
-
项目类别:
-
资助金额:$52.81万
-
财政年份:2020
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Multi-omic 3D tissue maps for a Human BioMolecular Atlas
-
批准号:10649957
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
-
批准号:10263321
-
项目类别:
-
资助金额:$116.62万
-
财政年份:2020
-
负责人:CLAYTON E MATHEWS
-
依托单位:
Genetic Regulation of Human Beta Cell Destruction
-
批准号:8813679
-
项目类别:
-
资助金额:$311.66万
-
财政年份:2014
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7998873
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2010
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:8297271
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:8475461
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7679743
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7470074
-
项目类别:
-
资助金额:$25.79万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7144848
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7265206
-
项目类别:
-
资助金额:$11.19万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7655273
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:8668040
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7771501
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位:
mt-Nd2 and Resistance to Autoimmune Diabetes
-
批准号:7613983
-
项目类别:
-
资助金额:$15.29万
-
财政年份:2006
-
负责人:CLAYTON E MATHEWS
-
依托单位: